Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Western blot [1]
- Immunoprecipitation [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 15731-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#15731-1-AP, RRID:AB_2154586
- Product name
- NUF2 antibody
- Antibody type
- Polyclonal
- Description
- NUF2 antibody (Cat. #15731-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IP, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references NDC80 kinetochore complex component is a potential molecular target of adenoid cystic carcinoma.
NUF2 activated by YY1 promotes prostate cancer malignancy via p38/MAPK signaling axis and serves as a therapeutic target.
NUF2 and NEK2 promote malignant progression of gallbladder cancer by remodeling the extracellular matrix.
CCDC68 Maintains Mitotic Checkpoint Activation by Promoting CDC20 Integration into the MCC.
NUF2 Drives Clear Cell Renal Cell Carcinoma by Activating HMGA2 Transcription through KDM2A-mediated H3K36me2 Demethylation.
NUF2 overexpression contributes to epithelial ovarian cancer progression via ERBB3-mediated PI3K-AKT and MAPK signaling axes.
LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription.
LUBAC controls chromosome alignment by targeting CENP-E to attached kinetochores.
Label-free Quantitative Analysis of Protein Expression Alterations in miR-26a-Knockout HeLa Cells using SWATH-MS Technology.
Yan X, He S, Lin Y, Zhang J, Huan J, Chen H, Lu L
Oncology letters 2026 Mar;31(3):114
Oncology letters 2026 Mar;31(3):114
NUF2 activated by YY1 promotes prostate cancer malignancy via p38/MAPK signaling axis and serves as a therapeutic target.
Jin C, Xu J, Luo W, Guo H, Ding L, Liu Y, Liu J, Zou L, Yu Y, Hao Y, Yang B
Biochemical pharmacology 2025 Jul;237:116919
Biochemical pharmacology 2025 Jul;237:116919
NUF2 and NEK2 promote malignant progression of gallbladder cancer by remodeling the extracellular matrix.
Gao M, Ye P, Zhang Y, Guo Y, Xu J
Carcinogenesis 2025 Apr 3;46(2)
Carcinogenesis 2025 Apr 3;46(2)
CCDC68 Maintains Mitotic Checkpoint Activation by Promoting CDC20 Integration into the MCC.
Li Q, Chen Q, Zheng T, Wang F, Teng J, Zhou H, Chen J
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 Sep;11(35):e2406009
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 Sep;11(35):e2406009
NUF2 Drives Clear Cell Renal Cell Carcinoma by Activating HMGA2 Transcription through KDM2A-mediated H3K36me2 Demethylation.
Lin J, Chen X, Yu H, Min S, Chen Y, Li Z, Xie X
International journal of biological sciences 2022;18(9):3621-3635
International journal of biological sciences 2022;18(9):3621-3635
NUF2 overexpression contributes to epithelial ovarian cancer progression via ERBB3-mediated PI3K-AKT and MAPK signaling axes.
Leng R, Meng Y, Sun X, Zhao Y
Frontiers in oncology 2022;12:1057198
Frontiers in oncology 2022;12:1057198
LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription.
Xie X, Lin J, Fan X, Zhong Y, Chen Y, Liu K, Ren Y, Chen X, Lai D, Li X, Li Z, Tang A
Cell death & disease 2021 Feb 19;12(2):201
Cell death & disease 2021 Feb 19;12(2):201
LUBAC controls chromosome alignment by targeting CENP-E to attached kinetochores.
Wu M, Chang Y, Hu H, Mu R, Zhang Y, Qin X, Duan X, Li W, Tu H, Zhang W, Wang G, Han Q, Li A, Zhou T, Iwai K, Zhang X, Li H
Nature communications 2019 Jan 17;10(1):273
Nature communications 2019 Jan 17;10(1):273
Label-free Quantitative Analysis of Protein Expression Alterations in miR-26a-Knockout HeLa Cells using SWATH-MS Technology.
Shen H, Li L, Teng Z, Meng T, Kong X, Hu Y, Zhu Y, Ma L
Scientific reports 2019 Feb 4;9(1):1399
Scientific reports 2019 Feb 4;9(1):1399
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HEK-293 cells were subjected to SDS PAGE followed by western blot with 15731-1-AP(NUF2 antibody) at dilution of 1:500
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The NUF2 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human NUF2. This antibody recognizes human,mouse,rat antigen. The NUF2 antibody has been validated for the following applications: ELISA, WB, IP analysis.
